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On June 18, 2013, the organ procurement and transplant network 
(OPTN) implemented the, “Share-35” scheme; a change to de-
ceased donor liver allocation. Under Share-35, all candidates in a 
region with a MELD (Model for End Stage Liver Disease) ≥ 35 
have priority over local candidates with MELD < 35. This policy 
entails prioritization of  liver transplant candidate; the sickest first. 
The main purpose of  this allocation policy is to reduce waitlist 
mortality. 
Since the adoption of  this policy, more patients (28%) have 
been transplanted at high MELD scores (> 30) compared to 
transplant recipients in or prior to 2012 or [1738 (2012 actual) 
vs. 2128 (2014 actual)] [1]. A preliminary analysis evaluating the 
impact of  this policy was presented at World Transplant Con-
gress in San Francisco, USA in the spring of  2014 [2]. Adjust-
ing for candidate MELD, under Share-35 the liver transplant rate 
was 19% higher for candidates with MELD≥35 (RR=1.08 1.19 
1.31, p<0.001), with no change for candidates with lower MELD 
scores (RR=0.94 1.00 1.07, p=0.9).  The MELD-adjusted wait-
list mortality decreased by 19% (RR=0.73 0.81 0.91, p<0.001). A 
recent analysis based on UNOS data revealed that with current 
allocation system patients with end stage liver disease were dis-
advantaged compared to those patients with exceptions points in 
particular with HCC [3].
Transplantation of  high MELD patients is challenging in all re-
spect. Among high MELD recipients, outcome is futile in about 
25% of  such recipients with or without transplantation resulting 
in wastage of  organs within first year of  transplantation [4,5]. In 
other words we have to lose one allograft and patient to save 3 
lives. It is also evident that the majority of  such patients have re-
nal dysfunction, and creatinine > 2mg/dl is associated with poor 
transplant survival regardless of  the pre transplant MELD score 
[6]. Despite the absence of  precise indication or concise criteria 
for simultaneous liver kidney transplantation (SLK), the number 
of  such recipients has gone up by 10%. Moreover a recent re-
port based on UNOS data has shown that in high MELD re-
cipients even SLK could not prevent recipient mortality [7]. This 
approach not only results in loss of  liver allografts but also kid-
ney allografts, which could otherwise be used for ESRD patients. 
The current approach might help reduce waitlist mortality but at 
the expense of  higher post-transplant mortality. Other important 
post transplant issues that warrant some discussion include higher 
rates of  renal dysfunction and SLK  transplantation, higher rates 
of  malnutrition, poor performance status, infections, increased 
length of  stay in hospital post transplanta tion and higher cost. 
The gap between the need of  transplantation and availability of  
donor organs cannot be diminished unless some alternatives are 
developed. For instance It is expected that with curative treat-
ment of  HCV (hepatitis C virus), there will be a reduction in the 
number of  patients requiring liver transplantation in the future 
and therefore this gap is expected to decrease. Nonetheless it is 
imperative to maximize utilization of  the available donor pool 
and from an outcome perspective this would mean aiming for 
higher numbers of  life years saved.What is therefore the goal of  
prioritization? Are we aiming at reducing waitlist mortality, im-
proving post-transplant survival, improving survival benefit or 
maximizing resource utilization? An ideal candidate and time of  
transplantation should incorporate the following expected fac-
tors; lower estimated waitlist mortality, greater than 95% one year 
post transplant survival (expecting almost 5% surgical risk mor-
tality), shorter length of  stay in hospital, decreased rate of  post-
transplant complications, rapid recovery to normal functioning, 
no utilization of  simultaneous kidney allograft and maximizing 
life year saved. The MELD score is good at predicting pre trans-
plantation mortality but is not good at predicting post transplan-
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tation mortality [4,5,8]. Indeed there are reports indicating that 
the pre transplant MELD score has an inverse relationship with 
post-transplant survival [4,5]. Several other models have been 
tested to determine post transplantation survival but none has 
high predictive ability [9-13]. 
In conclusion with the current approach the risks may outweigh 
the benefits and a rethink of  the share 35 policy is necessary. What 
is more acceptable, more deaths pre transplant or post-transplant? 
An ideal window or time for transplantation is yet to be deter-
mined; certainly the highest MELD point does not determine the 
ideal timing. 
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